{"id":764794,"date":"2023-06-20T10:21:15","date_gmt":"2023-06-20T14:21:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/"},"modified":"2023-06-20T10:21:15","modified_gmt":"2023-06-20T14:21:15","slug":"prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/","title":{"rendered":"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">MONSEY, N.Y., June  20, 2023  (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the $2.15 per share in cash, plus a contingent value right (CVR), at which Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) (\u201cParatek\u201d) has agreed to be sold to Gurnet Point Capital and Novo Holdings.<\/p>\n<p align=\"left\">If you remain a Paratek shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge:<\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JCu44QVd3TWcwwlClVZ5n_g--ywg02KFWXqg6fI77yHbpkfXZV7vePqfJsv7XH69M5DQFieDps-9OarIKpxHEcAti9p32XCdLntFX_RoizNZnqQ5oy_hklkIDs6q2rI_EbNUYxSSjxyFkB76h0W7aDIghPi9Msp7PDWyMXamY1er6qmhxqxK1NJhxbK0MTA3\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wohlfruchter.com\/cases\/paratek-pharmaceuticals-inc\/<\/a>\n      <\/p>\n<p align=\"left\">Alternatively, you may contact us by phone at 866-833-6245, or via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tOSQwDy0CHB3oBUB-55l3JsRnuzXNtEfQX8_ePJWGbD6pqgQ2x_6jZXsbAOvk76PhPiNRNtbauf6R_6aYeU39aR8c73FtqRrR3-_IlIyfn8=\" rel=\"nofollow noopener\" target=\"_blank\">alerts@wohlfruchter.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Why is there an investigation?<\/strong><br \/>\n        <br \/>On June 6, 2023, Paratek announced that it had agreed to be sold to Gurnet Point Capital and Novo Holdings for $2.15 per share in cash, plus a CVR of $0.85 per share payable upon the achievement of $320 million in U.S. NUZYRA net sales in any calendar year ending on or prior to December 31, 2026 (subject to exclusion of certain permitted deductions, payments under Paratek\u2019s contract with ASPR-BARDA, certain government payments and certain royalty revenue).<\/p>\n<p align=\"left\">\u201cWe are investigating whether the Paratek Board of Directors acted in the best interests of Paratek shareholders in approving the sale,\u201d explained Joshua Fruchter, a founding partner of Wohl &amp; Fruchter. \u201cThis includes whether the price agreed upon is fair to Paratek shareholders, and whether all material information regarding the transaction has been fully disclosed.\u201d<\/p>\n<p align=\"left\">Notably, according to an analysis of Wall Street price targets for Paratek in the last 90 days published on Seeking Alpha, there is a high price target of $5.00 per share, and an average price target of $3.10 per share, which indicates that most Wall Street analysts think the deal price is too low.<\/p>\n<p align=\"left\">Additionally, on Seeking Alpha, an investor with the screen name of David Kincaid has observed that the \u201cCVR payment terms are particularly bad\u201d because, aside from the exclusions, the \u201c[s]ales goal must be reached in a calendar year\u2014not cumulative, or even over a 12-month period\u2014and only US sales are included, [and] non-US sales [are] excluded.\u201d<\/p>\n<p align=\"left\">\n        <strong>About Wohl &amp; Fruchter <\/strong><br \/>\n        <br \/>Wohl &amp; Fruchter LLP has for over a decade been representing investors in litigation arising from fraud and other corporate misconduct, and recovered hundreds of millions of dollars in damages for investors. Please visit our website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kmQ5iR5gISXtyVybju4NzCeif062n5aJ9p5Q0-Xw8arbOW8qbCQwYHORee30XF7ohph957kvmGDbNyNh-5Xg8wJuuU0ors2RFPVQK39Rr2I=\" rel=\"nofollow noopener\" target=\"_blank\">www.wohlfruchter.com<\/a>, to learn more about our Firm, or contact one of our partners.<\/p>\n<p align=\"left\">\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Wohl &amp; Fruchter LLP<br \/>Joshua E. Fruchter <br \/>Toll Free 866.833.6245<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tOSQwDy0CHB3oBUB-55l3JsRnuzXNtEfQX8_ePJWGbC2Glu3nQpfim1NELB2ufsoRT3Y2KKI32E9ejdx00i-CfqqT6k3GYpTh5arFOufJwM=\" rel=\"nofollow noopener\" target=\"_blank\">alerts@wohlfruchter.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kmQ5iR5gISXtyVybju4NzCeif062n5aJ9p5Q0-Xw8aqJ3tiGfO6cMmkv_z_u3UK-nSUmi4N64Yu7zkIl2AfxXF9mqQmFSzXcS-0wGxynTlI=\" rel=\"nofollow noopener\" target=\"_blank\">www.wohlfruchter.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/N2JiNzI2ZmQtMDRjMi00OWI5LTg3ODUtNTJiYWMyZmNiM2RkLTEyNDQ4MzA=\/tiny\/Wohl-Fruchter-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MONSEY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the $2.15 per share in cash, plus a contingent value right (CVR), at which Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) (\u201cParatek\u201d) has agreed to be sold to Gurnet Point Capital and Novo Holdings. If you remain a Paratek shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge: https:\/\/wohlfruchter.com\/cases\/paratek-pharmaceuticals-inc\/ Alternatively, you may contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com. Why is there an investigation? On June 6, 2023, Paratek announced that it had agreed to be sold to Gurnet Point Capital &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-764794","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MONSEY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the $2.15 per share in cash, plus a contingent value right (CVR), at which Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) (\u201cParatek\u201d) has agreed to be sold to Gurnet Point Capital and Novo Holdings. If you remain a Paratek shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge: https:\/\/wohlfruchter.com\/cases\/paratek-pharmaceuticals-inc\/ Alternatively, you may contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com. Why is there an investigation? On June 6, 2023, Paratek announced that it had agreed to be sold to Gurnet Point Capital &hellip; Continue reading &quot;PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-20T14:21:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings\",\"datePublished\":\"2023-06-20T14:21:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/\"},\"wordCount\":437,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/\",\"name\":\"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=\",\"datePublished\":\"2023-06-20T14:21:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/","og_locale":"en_US","og_type":"article","og_title":"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings - Market Newsdesk","og_description":"MONSEY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the $2.15 per share in cash, plus a contingent value right (CVR), at which Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) (\u201cParatek\u201d) has agreed to be sold to Gurnet Point Capital and Novo Holdings. If you remain a Paratek shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge: https:\/\/wohlfruchter.com\/cases\/paratek-pharmaceuticals-inc\/ Alternatively, you may contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com. Why is there an investigation? On June 6, 2023, Paratek announced that it had agreed to be sold to Gurnet Point Capital &hellip; Continue reading \"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-20T14:21:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings","datePublished":"2023-06-20T14:21:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/"},"wordCount":437,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/","name":"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=","datePublished":"2023-06-20T14:21:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2MDg3NyM1NjU0ODA3IzIyMzMyNzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prtk-alert-monsey-firm-of-wohl-fruchter-investigating-fairness-of-the-sale-of-paratek-pharmaceuticals-to-gurnet-point-capital-and-novo-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PRTK Alert: Monsey Firm of Wohl &amp; Fruchter Investigating Fairness of the Sale of Paratek Pharmaceuticals to Gurnet Point Capital and Novo Holdings"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/764794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=764794"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/764794\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=764794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=764794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=764794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}